Characteristic | No/mild fibrosis (stage 0–2) | Advanced fibrosis (stage 3–4) | p Value |
Age (years) | 49±12 | 61±8 | <0.001* |
Gender (%male) | 65% | 41% | 0.02‡ |
BMI (kg/m2) | 35±5 | 36±7.6 | 0.13* |
BMI ≥28 | 96% | 100% | 0.58‡ |
Diabetes | 49% | 56% | 0.54‡ |
Waist circumference (cm) | 111±11 | 113±12 | 0.34* |
ALT (IU/l) | 101±66 | 68±40 | 0.001* |
AST (IU/l) | 63±44 | 67±43 | 0.65* |
GGT (IU/l) | 122±109 | 262±398 | 0.08* |
ALB (g/l) | 45±3 | 44±9 | 0.6* |
Platelets (×109/litre) | 267±90 | 204±78 | 0.001* |
Cholesterol (mmol/l) | 5.5±1.3 | 4.8±1.3 | 0.01* |
Trigycerides (mmol/l) | 2.9±2.4 | 1.8±0.9 | <0.001* |
APRI | 0.65±0.52 | 0.94±0.58 | 0.01* |
AST/ALT ratio | 0.67±0.23 | 1.05±0.39 | <0.001* |
BARD score | 2 (0–4) | 3 (1–4) | <0.001† |
Fib-4 score | 1.25±0.79 | 2.83±1.71 | <0.001* |
NAFLD score | −1.83±1.52 | 1.52±1.75 | <0.001* |